Search

Your search keyword '"Alexandre A."' showing total 1,858 results

Search Constraints

Start Over You searched for: Author "Alexandre A." Remove constraint Author: "Alexandre A." Journal blood Remove constraint Journal: blood
1,858 results on '"Alexandre A."'

Search Results

1. A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels

2. DOCK11 deficiency in patients with X-linked actinopathy and autoimmunity

3. Whole-genome analysis of plasma fibrinogen reveals population-differentiated genetic regulators with putative liver roles

4. The NFIA-ETO2 fusion blocks erythroid maturation and induces pure erythroid leukemia in cooperation with mutant TP53

5. S100A8/A9 drives the formation of procoagulant platelets through GPIbα

6. Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays

7. Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL

8. SAR442085, a novel anti-CD38 antibody with enhanced antitumor activity against multiple myeloma

9. Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies

11. Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group

13. Factors Associated with Prolonged CRS and Neurotoxicity after Treatment with Axicabtagene Ciloleucel

17. Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survival

18. Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism

19. EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome

20. Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura

21. A mutation of the human EPHB2 gene leads to a major platelet functional defect

22. An updated list of drugs suspected to be associated with immune thrombocytopenia based on the WHO pharmacovigilance database

23. DNA methylation age is associated with an altered hemostatic profile in a multiethnic meta-analysis

24. AMPK-ACC signaling modulates platelet phospholipids and potentiates thrombus formation

25. Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease

26. S100A8/A9 drives the formation of procoagulant platelets through GPIbα

27. Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients with Acute Myeloid Leukemia: Analysis of Outcomes and Contemporary Trends Spanning 10 Years

28. DOCK11 deficiency in patients with X-linked actinopathy and autoimmunity

29. Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy–associated C3 glomerulopathy

33. The Novel Trifunctional Anti-BCMA NK Cell Engager SAR'514 Has Potent in-Vitro and in-Vivo Anti-Myeloma Effect through Dual NK Cell Engagement

34. PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study

36. Achievement of Measurable Residual Disease (MRD) Negativity Supersedes Treatment Intensity in Predicting the Outcome of Patients with Acute Myeloid Leukemia

38. CAR T-Cell Therapy for Relapsed or Refractory Large B-Cell Lymphoma Using a Fully Human CD19-Targeted Single Chain Variable Fragment: Results of a First-in-Human Phase I/II Study

39. Timing of PD-L1 Blockade with Durvalumab May Affect Outcomes of CD19 CAR-T Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma

40. A Phase II Study of Azacitidine Plus Venetoclax As Maintenance Therapy in Acute Myeloid Leukemia: Durable Responses with Longer Term Follow-up

43. Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL

46. The NFIA-ETO2 fusion blocks erythroid maturation and induces pure erythroid leukemia in cooperation with mutant TP53

47. SAR442085, a novel anti-CD38 antibody with enhanced antitumor activity against multiple myeloma

48. The Novel Trifunctional Anti-BCMA NK Cell Engager SAR'514 Has Potent in-Vitro and in-Vivo Anti-Myeloma Effect through Dual NK Cell Engagement

Catalog

Books, media, physical & digital resources